Interview with Wojciech Przybys, Vice President Northeastern Europe, Quintiles…
Firstly, what attracted you to join the CRO industry with Quintiles over 10 years ago? I had been working for 5 years as a doctor in the internal medicine and…
Address: Ul.Gottlieba Daimlera 1,02-460,Warszawa,Poland
Tel: +48 22 43 03 100
Web: http://www.quintiles.com/locations/europe/poland/
Quintiles Poland has been in operation since 1999, providing expert, innovative clinical services and solutions for our customers. Our office houses highly trained clinical monitors, study site coordinators and project managers. Quintiles Poland offers our experience to pharmaceutical companies around the globe.
Key Services in Poland to Support Your Clinical Trials
Clinical Monitoring and Site Management
Medical and Scientific Services
Project Coordination Centers
Project management
Quality Assurance
Access through Our Poland Team to Quintiles Worldwide
Access to Patients Services
Biostatistics
Central Labs
Data management
Drug safety/pharmacovigilance
ECG services
Regulatory specialists
Consulting Services
Partnering
Firstly, what attracted you to join the CRO industry with Quintiles over 10 years ago? I had been working for 5 years as a doctor in the internal medicine and…
“We have made some progress in terms of the conceptualization of depression as a disease. Previously, the popular attitude was that depression was a temporary emotion; one that could be…
IMS’ General Manager, Maciej Kuzmierkiewicz, discusses the effects of the Reimbursement Act—the new legislative framework implemented in January 2012—which completely reshaped the rules of the game for the Polish pharmaceutical sector…
You have been heading the affiliate since its creation in 1997; therefore you saw its evolution and growth. Would you say that Apotex Poland has evolved in accordance with the…
You have been heading the affiliate since its creation in 1997; therefore you saw its evolution and growth. Would you say that Apotex Poland has evolved in accordance with the…
You have been quite recently appointed at the head of the Polish affiliate of AstraZeneca. With which personal ambitions did you come and what was the mission you were given…
The pharmaceutical industry market growth, including generics and originator drugs, is today steady and sustainable. The market size is over 5 billion Euros which makes Poland the 6th biggest market…
You were appointed general manager of Astellas Poland in early 2006, only a bit after Astellas Pharma Inc. was established, on April 1, 2005 through the merger of the mother…
BAUSCH + LOMB has over 150 years of heritage and has always been associated with optics and ophthalmology. Therefore the company has been able to build a very strong brand…
Given Cegedim’s global reach and your 13 year experience of operating as a consultant to the Polish pharma industry, how would you describe the market to the international readers of…
As Squibb Corporation and Bristol-Myers merged in 1989, Bristol-Myers Squibb has been officially operating in this market since that date, but the affiliate has a long history previous to that.…
Would you begin by explaining to the readers of Pharmaceutical Executive the importance of the operation in Poland for the company? Indeed Poland because of largest in CEE pharmaceutical market…
Firstly, what attracted you to join the CRO industry with Quintiles over 10 years ago? I had been working for 5 years as a doctor in the internal medicine and…
See our Cookie Privacy Policy Here
